Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells.
about
TLR7/TLR8 Activation Restores Defective Cytokine Secretion by Myeloid Dendritic Cells but Not by Plasmacytoid Dendritic Cells in HIV-Infected Pregnant Women and NewbornsAnimal Models for HIV Cure ResearchDendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?Innate immune recognition of HIV-1Plasmacytoid dendritic cells and type I IFN: 50 years of convergent historyHepatitis C Virus Is a Weak Inducer of Interferon Alpha in Plasmacytoid Dendritic Cells in Comparison with Influenza and Human Herpesvirus Type-1Are T cells the only HIV-1 reservoir?HIV-1 and hijacking of the host immune system: the current scenario.Major depletion of plasmacytoid dendritic cells in HIV-2 infection, an attenuated form of HIV diseaseImpact of HIV on cell survival and antiviral activity of plasmacytoid dendritic cellsTranscriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonistsSelective transmission of R5 HIV-1 over X4 HIV-1 at the dendritic cell-T cell infectious synapse is determined by the T cell activation state.HIV-1 infection of DC: evidence for the acquisition of virus particles from infected T cells by antigen uptake mechanism.Plasmacytoid dendritic cells in HIV infection: striking a delicate balance.Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineageNeutralizing antibodies inhibit HIV-1 infection of plasmacytoid dendritic cells by an FcγRIIa independent mechanism and do not diminish cytokines production.Effect of plasma viremia on apoptosis and immunophenotype of dendritic cells subsets in acute SIVmac239 infection of Chinese rhesus macaquesLack of clinical AIDS in SIV-infected sooty mangabeys with significant CD4+ T cell loss is associated with double-negative T cells.Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells.HIV-1 Nef enhances dendritic cell-mediated viral transmission to CD4+ T cells and promotes T-cell activation.Dendritic cell recruitment in response to skin antigen tests in HIV-1-infected individuals correlates with the level of T-cell infiltration.Broadly neutralizing antibody VRC01 prevents HIV-1 transmission from plasmacytoid dendritic cells to CD4 T lymphocytes.Differential effects of Vpr on single-cycle and spreading HIV-1 infections in CD4+ T-cells and dendritic cells.Evidence of dysregulation of dendritic cells in primary HIV infection.A look behind closed doors: interaction of persistent viruses with dendritic cells.In vitro HIV infection impairs the capacity of myeloid dendritic cells to induce regulatory T cells.Dendritic cell subsets dynamics and cytokine production in SIVmac239-infected Chinese rhesus macaques.HIV-1 replication in Langerhans and interstitial dendritic cells is inhibited by neutralizing and Fc-mediated inhibitory antibodies.Dendritic-cell interactions with HIV: infection and viral dissemination.Attachment and fusion inhibitors potently prevent dendritic cell-driven HIV infectionBinding of HIV-1 gp120 to DC-SIGN promotes ASK-1-dependent activation-induced apoptosis of human dendritic cells.Gaining a foothold: how HIV avoids innate immune recognition.Effect of methamphetamine on expression of HIV coreceptors and CC-chemokines by dendritic cells.Interleukin-27 is a potent inhibitor of cis HIV-1 replication in monocyte-derived dendritic cells via a type I interferon-independent pathwayDendritic cells in progression and pathology of HIV infection.Efficient infection, activation, and impairment of pDCs in the BM and peripheral lymphoid organs during early HIV-1 infection in humanized rag2⁻/⁻γ C⁻/⁻ mice in vivo.HIV-1 capture and transmission by dendritic cells: the role of viral glycolipids and the cellular receptor Siglec-1Nuclear receptor signaling inhibits HIV-1 replication in macrophages through multiple trans-repression mechanismsBlocking type I interferon production: a new therapeutic option to reduce the HIV-1-induced immune activationPotent Cell-Intrinsic Immune Responses in Dendritic Cells Facilitate HIV-1-Specific T Cell Immunity in HIV-1 Elite Controllers.
P2860
Q24297513-309DFC8A-63C4-4823-A53F-89D65EC3BD37Q26767476-62A20E7D-489D-45F3-BFFC-4C5AA8F09CF9Q27010312-2D2E7C53-F33B-4096-9FA5-0F16CCCFD669Q27025598-48D86E4F-F902-4951-85BF-B7C852649862Q27485637-228A2FF7-423D-4C98-8710-9898C721DFB5Q27487765-436E5B23-0FA2-4E2D-B3C0-545A694E957DQ28078850-9068D285-01F9-46F7-B603-CE7C3FA7490CQ30248405-FF946C6F-0B93-481F-875C-D9A51D1FDF8BQ30912292-B115E3EA-30F2-4655-8F4D-C21847F53DCBQ33285471-C3CBCBC8-6E4B-4B80-AFC1-A073F5EBA63DQ33302568-CA02967C-AC6D-4D05-BC5D-6F8486D4E43CQ33404066-400AD1FA-3999-4A0A-9C02-CDC7577C66AAQ33510694-03EF4A1B-83DF-4F65-A5CE-9899BDB41EB1Q33805319-07C5C0D8-5391-46D1-ACBB-6A8E486F9D8DQ33864438-DB4C5D70-0192-4F61-A693-1CEB8B76EF61Q34055377-5DD55D4E-A4C1-42D8-907D-359315FEDA43Q34103595-11E86B70-0ED4-45A1-BA65-72425058E862Q34164295-6E5B462D-DC4A-4FF9-937F-587959A7F5E9Q34192846-164B3082-675B-4859-A582-DB5F445A0783Q34222643-DEBB6DC8-6520-46D4-A76C-19A2CE564E93Q34251469-A3BB9C0E-CEB3-443F-AFF5-ED951D09E39CQ34262089-0E1197AE-C6EF-4EB9-962D-90E2B7B966E1Q34263217-AA190214-30CA-4386-956F-C7818E68EF31Q34310896-E1D08915-D4DB-486E-8473-EF26EA75A468Q34335916-6AE31908-B2C6-44B8-9AEA-E843FDEB2DA5Q34388925-0B16DAD6-8F68-4AB1-9435-AAF646502433Q34412070-2F57B2F0-BBBC-4D94-876A-601150BB0F87Q34485336-C8E6F032-85C6-4668-BB07-E14730B26A36Q34572043-C2B6F66C-381F-4D4A-9F4A-C426DFFD5C28Q34574462-177321FE-BA6B-4D3F-85CB-B3FB8E03F827Q34574823-0DD43248-A6B8-441E-A564-44484DB7723DQ34590321-8725BCBD-D622-4E23-AAF1-EEF5B7C7F9F0Q34605233-51C72BA8-5430-4572-9080-9EC124723571Q34634806-0C78B6F3-E6A2-41E6-B912-DBFCE9D74138Q34657557-2559C0B8-D215-448E-95D5-34CD0EEF4056Q35067382-D43FBD95-F225-483A-BAB0-924079064E79Q35208189-6EA67A97-174A-46C7-8101-4DFE2FB335EAQ35274791-D6D6F961-76BB-4526-9FE1-DD997AF6F480Q35606616-EE6F7489-65D8-49BC-9FA6-04FB61746B1DQ35661586-8B5C073C-ADB3-4BC9-9140-DB1BA431203A
P2860
Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Differential susceptibility to ...... plasmacytoid dendritic cells.
@ast
Differential susceptibility to ...... plasmacytoid dendritic cells.
@en
type
label
Differential susceptibility to ...... plasmacytoid dendritic cells.
@ast
Differential susceptibility to ...... plasmacytoid dendritic cells.
@en
prefLabel
Differential susceptibility to ...... plasmacytoid dendritic cells.
@ast
Differential susceptibility to ...... plasmacytoid dendritic cells.
@en
P2093
P2860
P1433
P1476
Differential susceptibility to ...... plasmacytoid dendritic cells.
@en
P2093
Anna Smed-Sörensen
Anna-Lena Spetz
Jan Andersson
Jayanand Vasudevan
Karin Loré
Mark K Louder
Richard A Koup
P2860
P304
P356
10.1128/JVI.79.14.8861-8869.2005
P577
2005-07-01T00:00:00Z